POLE and cancer: To assess the likelihood of mutations in these genes being secondary to an earlier POLE mutation, we developed a metric to score them according to the probability that they were caused by the mutational process dominant in POLE‐mutant cancers (presumably caused by the POLE mutation itself), rather than the mutational processes operative in other tumours (see Materials and methods, ‘POLE consensus mutational signature scores in driver genes’ for details).